Immunotherapy in colorectal cancer: current achievements and future perspective

Following dramatic success in many types of advanced solid tumors, interest in immunotherapy for the treatment of colorectal cancer (CRC) is increasingly growing. Given the compelling long-term durable remission, two programmed cell death 1 (PD-1)-blocking antibodies, pembrolizumab and nivolumab (wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Ahui, Wang, Boda, Wang, Xin, Nie, Yongzhan, Fan, Daiming, Zhao, Xiaodi, Lu, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495390/
https://www.ncbi.nlm.nih.gov/pubmed/34671202
http://dx.doi.org/10.7150/ijbs.64077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495390/
https://www.ncbi.nlm.nih.gov/pubmed/34671202
http://dx.doi.org/10.7150/ijbs.64077

Ejemplares similares